EFTA02573105.pdf

From: Sent: Wednesday, November 1, 2017 4:43 PM To: Jeffrey E. Cc: Steven Sinofsky Subject: Re: Thank you Jeffrey. Steve, g=eat meeting you. Would appreciate your feedback =div> On Nov 1, 2017, at 9:31 AM, Jeffrey E. <[email protected] <mailto:[email protected]» wrote: steve can you give some guidance <=div> On Wed, Nov 1= 2017 at 12:20 PM =span style="background-color:rgba(255,255,255,0)">I'm looking to invest a= the company doing Al-based glucose monitoring system for people with diabe=es. We made tech evaluation, talked to a few experts and more a quest=on about the market and regulations. Likely no, because it's complex a=ea, but still thinking of them. May be someone in your network who knows thi= area and can advise on this kind of tech? Center Health Deck: https://drive.go=gle.com/file/d/0BSO93D3IJArEbX8sdll4elVob0U/view <https://drive.google=com/file/d/095O93D3IJArEbX8sdll4elVob0U> <=div> Ou= memo: https://docs.google.co=/document/d/1M7ZV7VEISCTnb4EtYWFH2sq5dcCm0PM6g1AlcwrIOtM chttps://docs.google.com/document/d/1M72V7VEI8=Tnb4EtYWFH2sacCm0PM6g1AlcwrIOtM> =/div> =br> Center Health is building an Al-based glucos= monitoring system for the 1 in 11 Americans who suffer from diabetes,=based on machine learning and their personalized Al, Aria. Users subsc=ibe to their disposable test strips, a $14B/yr US market, which are deliver=d monthly, as Aria learns about their diabetes and prompts behavioral chang=s to lower blood sugar. The system is an order of magnitude cheap=r than existing technologies, premised on leveraging data to help users see=what daily elements are affecting their blood sugar, and predicting da=gerous highs and lows before they happen. Pros — Existing glucometers from big companies are very ol=-fashioned and outdated, those companies make their revenue from overpriced=strips — Direct competitors, such as iHeal=h and Dario have negative customer reviews and minor — Uses FD=-approved circuits to get the approval in an automated manner <=iv style="font-weight:normal"> =/font> EFTA_R1_01742973 EFTA02573105  Cons — Enormous pressure both f=om the industry players and companies such as Apple and Google that try to d=velop non-invasive glucose monitoring that will wipe out test strip product= — Hardware startup without a product to sell yet, fin=lizing the development — Young team please note The i=formation contained in this communication is confidential, may be attorn=y-client privileged, may constitute inside information, and is intended o=ly for the use of the addressee. It is the property of JEE Unautho=ized use, disclosure or copying of this communication or any part thereo= is strictly prohibited and may be unlawful. If you have received thiscommunication in error, please notify us immediately by return e-mail o= by e-mail to [email protected] <mailto:[email protected]> , and destroy this communication and all copies th=reof, including all attachments. copyright -all rights reserved 2 EFTA_R1_01742974 EFTA02573106